|
US10189841B2
(en)
|
2015-11-20 |
2019-01-29 |
Forma Therapeutics, Inc. |
Purinones as ubiquitin-specific protease 1 inhibitors
|
|
US20240182481A1
(en)
*
|
2021-02-15 |
2024-06-06 |
Tango Therapeutics, Inc. |
Pyrrolo[3,2-d]pyrimidine compounds and methods of use in the treatment of cancer
|
|
MX2023011709A
(es)
*
|
2021-04-07 |
2023-10-12 |
Forma Therapeutics Inc |
Inhibidor de la proteasa 1 especifica de ubiquitina (usp1).
|
|
EP4321515A4
(en)
*
|
2021-04-09 |
2025-06-25 |
Hainan Simcere Zaiming Pharmaceutical Co., Ltd. |
UBIQUITIN-SPECIFIC PROTEASE-1 INHIBITOR
|
|
KR102910851B1
(ko)
*
|
2021-04-21 |
2026-01-09 |
장춘 진사이언스 파마슈티컬 씨오., 엘티디. |
이미다졸 함유 축합고리계 유도체, 이의 제조방법 및 이의 의약적 용도
|
|
WO2022253188A1
(en)
*
|
2021-05-31 |
2022-12-08 |
Impact Therapeutics (Shanghai) , Inc |
Nitrogen-containing fused heteroaromatic bicyclic compounds as usp1 inhibitors and the use thereof
|
|
JP2024540921A
(ja)
*
|
2021-10-19 |
2024-11-06 |
上海瑛派▲薬▼▲業▼有限公司 |
Ｕｓｐ１阻害剤としての置換トリアゾロヘテロアリール化合物及びその応用
|
|
CR20240191A
(es)
|
2021-11-12 |
2024-09-13 |
Insilico Medicine Ip Ltd |
Inhibidores de molécula pequeña de proteasa 1 específica de ubiquitina (usp1) y usos de los mismos
|
|
US20250163049A1
(en)
*
|
2022-02-03 |
2025-05-22 |
Exelixis, Inc. |
Fused bicyclic heterocyclyl compounds as usp1 inhibitors
|
|
AU2023261809A1
(en)
*
|
2022-04-29 |
2024-12-05 |
Asieris Pharmaceuticals (Shanghai) Co., Ltd. |
Pyrimidine compound, method for preparing same, and pharmaceutical use thereof
|
|
WO2024006879A1
(en)
*
|
2022-06-29 |
2024-01-04 |
Zentaur Therapeutics Usa Inc. |
Usp1 inhibitors and uses thereof
|
|
WO2024022519A1
(zh)
*
|
2022-07-28 |
2024-02-01 |
先声再明医药有限公司 |
杂环并嘧啶类化合物及其应用
|
|
CN119790043A
(zh)
*
|
2022-08-26 |
2025-04-08 |
海南先声再明医药股份有限公司 |
三环类化合物及其应用
|
|
WO2024078436A1
(zh)
*
|
2022-10-09 |
2024-04-18 |
海南先声再明医药股份有限公司 |
杂环并嘧啶类化合物、药物组合物及其应用
|
|
WO2024086790A1
(en)
|
2022-10-21 |
2024-04-25 |
Exelixis, Inc. |
4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-c]PYRIDINE COMPOUNDS AND DERIVATIVES AS USP1 INHIBITORS
|
|
CN120603835A
(zh)
*
|
2023-01-20 |
2025-09-05 |
杭州英创医药科技有限公司 |
作为usp1抑制剂的化合物
|
|
WO2024233665A1
(en)
|
2023-05-08 |
2024-11-14 |
Tango Therapeutics, Inc. |
Compounds and their use against cancer
|
|
WO2024233605A1
(en)
|
2023-05-08 |
2024-11-14 |
Tango Therapeutics, Inc. |
Compounds and their use against cancer
|
|
WO2024236528A1
(en)
*
|
2023-05-18 |
2024-11-21 |
Insilico Medicine Ip Limited |
Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof
|
|
WO2025010245A1
(en)
|
2023-07-06 |
2025-01-09 |
Exelixis, Inc. |
Fused pyrazole derivatives as usp1 inhibitors
|
|
CN119930633B
(zh)
*
|
2023-11-06 |
2025-11-18 |
中国医学科学院药物研究所 |
一种吡咯并蝶啶酮类泛素特异性蛋白酶1抑制剂及其制备方法、用途和药物组合物
|
|
CN119930632B
(zh)
*
|
2023-11-06 |
2025-11-18 |
中国医学科学院药物研究所 |
一种三并环类泛素特异性蛋白酶1抑制剂及其制备方法、用途和药物组合物
|
|
WO2025102016A1
(en)
|
2023-11-10 |
2025-05-15 |
Vrise Therapeutics, Inc. |
Novel molecules as inhibitors of dna damage repair pathway
|
|
WO2025151705A1
(en)
|
2024-01-10 |
2025-07-17 |
Vrise Therapeutics, Inc. |
Novel inhibitors of dna damage repair pathway
|